XML 17 R28.htm IDEA: XBRL DOCUMENT v2.4.1.9
Investment in Unconsolidated Entities (Details) (USD $)
12 Months Ended 0 Months Ended
Dec. 31, 2014
Member
Dec. 31, 2013
May 31, 2014
Feb. 28, 2014
Dec. 31, 2011
Jun. 30, 2012
Dec. 31, 2012
Sep. 30, 2010
Jan. 31, 2013
The Southern California Regional Gamma Knife Center [Abstract]                  
Renovation installation and operation agreement period 14 years                
Condensed Income Statement Information [Abstract]                  
Patient revenue $ 2,607,000us-gaap_HealthCareOrganizationPatientServiceRevenue $ 0us-gaap_HealthCareOrganizationPatientServiceRevenue              
USNC's equity in income (loss) of investment in unconsolidated entities 14,000us-gaap_IncomeLossFromEquityMethodInvestments (31,000)us-gaap_IncomeLossFromEquityMethodInvestments              
Florida Oncology Partners [Abstract]                  
Recorded investments 323,000us-gaap_EquityMethodInvestments 320,000us-gaap_EquityMethodInvestments              
Due from related parties 8,000us-gaap_DueFromRelatedPartiesCurrent 316,000us-gaap_DueFromRelatedPartiesCurrent              
Boca Oncology Partners [Abstract]                  
Investment in unconsolidated entities 323,000us-gaap_EquityMethodInvestments 320,000us-gaap_EquityMethodInvestments              
Number of members who provided short term loans 3usnu_NumberOfMembersWhoProvidedShortTermLoans                
Proceeds from short-term loans 462,000us-gaap_ProceedsFromShortTermDebt 0us-gaap_ProceedsFromShortTermDebt              
Interest expense 184,000us-gaap_InterestExpense 15,000us-gaap_InterestExpense              
Accrued interest 15,000us-gaap_InterestReceivable                
USNC [Member]                  
Boca Oncology Partners [Abstract]                  
Reduced ownership percentage (in hundredths) 11.25%us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction
/ dei_LegalEntityAxis
= us-gaap_SubsidiariesMember
               
Boca Oncology Partners, LLC [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Losses against outstanding receivables   57,000usnu_GainsLossesAgainstAggregateOutstandingReceivables
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Condensed Income Statement Information [Abstract]                  
Patient revenue 115,000us-gaap_HealthCareOrganizationPatientServiceRevenue
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
2,386,000us-gaap_HealthCareOrganizationPatientServiceRevenue
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Net income (loss) (108,000)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
(206,000)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
USNC's equity in income (loss) of investment in unconsolidated entities (12,000)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
(23,000)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Condensed Balance Sheet Information [Abstract]                  
Current assets   640,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Noncurrent assets   1,831,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Total assets   2,471,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Current liabilities   730,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Noncurrent liabilities   2,126,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Equity   (385,000)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Total liabilities and equity   2,471,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Boca Oncology Partners [Abstract]                  
Area of real estate property 6,000us-gaap_AreaOfRealEstateProperty
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
               
Gain from sale of interests     33,000us-gaap_GainOnSaleOfInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
204,000us-gaap_GainOnSaleOfInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
         
Amount loaned to related parties 56,250us-gaap_PaymentsToFundLongtermLoansToRelatedParties
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
               
Debt maturity period 5 years                
Company loan interest rate (in hundredths) 7.00%us-gaap_DebtInstrumentInterestRateStatedPercentage
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
               
Losses against outstanding receivables   57,000usnu_GainsLossesAgainstAggregateOutstandingReceivables
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
             
Boca Oncology Partners, LLC [Member] | USNC [Member]                  
Boca Oncology Partners [Abstract]                  
Amount loaned to related parties 28,000us-gaap_PaymentsToFundLongtermLoansToRelatedParties
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersLlcMember
/ dei_LegalEntityAxis
= us-gaap_SubsidiariesMember
               
Boca Oncology Partners RE, LLC [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Ownership percentage (in hundredths) 15.40%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
      22.50%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
       
Condensed Income Statement Information [Abstract]                  
Rental income 0usnu_RentalIncomeOperating
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
0usnu_RentalIncomeOperating
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Net income (loss) (4,000)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
(1,000)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
USNC's equity in income (loss) of investment in unconsolidated entities 0us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
0us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Condensed Balance Sheet Information [Abstract]                  
Current assets 61,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
132,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Noncurrent assets 786,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
707,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Total assets 847,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
839,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Current liabilities 0us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
0us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Noncurrent liabilities 0us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
0us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Equity 847,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
839,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Total liabilities and equity 847,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
839,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Florida Oncology Partners [Abstract]                  
Recorded investments 134,000us-gaap_EquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
0us-gaap_EquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Ownership percentage by outside investors (in hundredths) 31.50%usnu_OwnershipPercentageByOutsideInvestors
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
               
Boca Oncology Partners [Abstract]                  
Percentage of interest in medical office building (in hundredths) 20.00%usnu_PercentageOfInterestInMedicalOfficeBuilding
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
               
Investment in unconsolidated entities 134,000us-gaap_EquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
0us-gaap_EquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Due to related parties 12,000us-gaap_DueToRelatedPartiesCurrentAndNoncurrent
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
0us-gaap_DueToRelatedPartiesCurrentAndNoncurrent
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
             
Boca Oncology Partners RE, LLC [Member] | USNC [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Ownership percentage (in hundredths) 11.25%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaOncologyPartnersReLlcMember
/ dei_LegalEntityAxis
= us-gaap_SubsidiariesMember
               
BOP and BOPRE [Member]                  
Florida Oncology Partners [Abstract]                  
Recorded investments         225,000us-gaap_EquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BopAndBopreMember
       
Ownership percentage by outside investors (in hundredths) 88.75%usnu_OwnershipPercentageByOutsideInvestors
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BopAndBopreMember
               
Due from related parties 0us-gaap_DueFromRelatedPartiesCurrent
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BopAndBopreMember
200,000us-gaap_DueFromRelatedPartiesCurrent
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BopAndBopreMember
             
Boca Oncology Partners [Abstract]                  
Area of real estate property 32,000us-gaap_AreaOfRealEstateProperty
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BopAndBopreMember
               
Investment in unconsolidated entities         225,000us-gaap_EquityMethodInvestments
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BopAndBopreMember
       
Additional investor purchased (in hundredths) 50.00%usnu_PercentageOfPartnershipOwnershipPurchasedByInvestors
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BopAndBopreMember
               
Boca West IMP [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Ownership percentage (in hundredths) 3.75%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaWestImpMember
        23.75%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BocaWestImpMember
     
BOP and USNC's [Member] | USNC [Member]                  
Boca Oncology Partners [Abstract]                  
Reduced ownership percentage (in hundredths) 15.40%us-gaap_SaleOfStockPercentageOfOwnershipAfterTransaction
/ us-gaap_InvestmentsInAndAdvancesToAffiliatesCategorizationAxis
= usnu_BopAndUsncSMember
/ dei_LegalEntityAxis
= us-gaap_SubsidiariesMember
               
CGK [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Ownership percentage (in hundredths)         44.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= usnu_CgkMember
  39.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= usnu_CgkMember
   
CGK [Member] | USNC [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Initial ownership percentage (in hundredths) 27.00%us-gaap_SaleOfStockPercentageOfOwnershipBeforeTransaction
/ dei_LegalEntityAxis
= us-gaap_SubsidiariesMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= usnu_CgkMember
               
Neuro Partners LLC [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Ownership percentage (in hundredths) 20.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= usnu_NeuroPartnersLlcMember
               
FOP and FOPRE [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Ownership percentage (in hundredths) 20.00%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
               
Condensed Income Statement Information [Abstract]                  
Patient revenue 2,631,000us-gaap_HealthCareOrganizationPatientServiceRevenue
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
2,836,000us-gaap_HealthCareOrganizationPatientServiceRevenue
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Net income (loss) 197,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
281,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
USNC's equity in income (loss) of investment in unconsolidated entities 39,000us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
56,000us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Condensed Balance Sheet Information [Abstract]                  
Current assets 606,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
653,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Noncurrent assets 5,070,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
5,795,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Total assets 5,676,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
6,448,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Current liabilities 858,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
893,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Noncurrent liabilities 3,947,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
4,881,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Equity 871,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
674,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Total liabilities and equity 5,676,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
6,448,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Florida Oncology Partners [Abstract]                  
Recorded investments 190,000us-gaap_EquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
151,000us-gaap_EquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
          200,000us-gaap_EquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
 
Ownership percentage by outside investors (in hundredths) 80.00%usnu_OwnershipPercentageByOutsideInvestors
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
               
Due from related parties 8,000us-gaap_DueFromRelatedPartiesCurrent
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
40,000us-gaap_DueFromRelatedPartiesCurrent
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
             
Boca Oncology Partners [Abstract]                  
Investment in unconsolidated entities 190,000us-gaap_EquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
151,000us-gaap_EquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
          200,000us-gaap_EquityMethodInvestments
/ us-gaap_VariableInterestEntitiesByClassificationOfEntityAxis
= us-gaap_VariableInterestEntityNotPrimaryBeneficiaryMember
 
Neuro Partners LLC and CGK [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Losses against outstanding receivables 45,000usnu_GainsLossesAgainstAggregateOutstandingReceivables
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
27,000usnu_GainsLossesAgainstAggregateOutstandingReceivables
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Condensed Income Statement Information [Abstract]                  
Patient revenue 1,223,000us-gaap_HealthCareOrganizationPatientServiceRevenue
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
1,040,000us-gaap_HealthCareOrganizationPatientServiceRevenue
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Net income (loss) 74,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
(180,000)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
USNC's equity in income (loss) of investment in unconsolidated entities 14,000us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
(75,000)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Condensed Balance Sheet Information [Abstract]                  
Current assets 92,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
521,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Noncurrent assets 991,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
1,626,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Total assets 1,083,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
2,147,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Current liabilities 829,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
1,272,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Noncurrent liabilities 969,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
1,664,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentLiabilities
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Equity (715,000)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
(789,000)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Total liabilities and equity 1,083,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
2,147,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Boca Oncology Partners [Abstract]                  
Losses against outstanding receivables 45,000usnu_GainsLossesAgainstAggregateOutstandingReceivables
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
27,000usnu_GainsLossesAgainstAggregateOutstandingReceivables
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_NeuroPartnersLlcAndCgkMember
             
Broward Oncology Partners, LLC [Member]                  
The Southern California Regional Gamma Knife Center [Abstract]                  
Ownership percentage (in hundredths)                 12.50%us-gaap_EquityMethodInvestmentOwnershipPercentage
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
Condensed Income Statement Information [Abstract]                  
Patient revenue 505,000us-gaap_HealthCareOrganizationPatientServiceRevenue
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
522,000us-gaap_HealthCareOrganizationPatientServiceRevenue
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
             
Net income (loss) 255,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
(120,000)us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNetIncomeLoss
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
             
USNC's equity in income (loss) of investment in unconsolidated entities 32,000us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
(15,000)us-gaap_IncomeLossFromEquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
             
Condensed Balance Sheet Information [Abstract]                  
Current assets   360,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
             
Noncurrent assets   239,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationNoncurrentAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
             
Total assets   599,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationAssets
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
             
Current liabilities   319,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationCurrentLiabilities
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
             
Equity   280,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
             
Total liabilities and equity   599,000us-gaap_EquityMethodInvestmentSummarizedFinancialInformationLiabilitiesAndEquity
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
             
Florida Oncology Partners [Abstract]                  
Recorded investments                 50,000us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
Boca Oncology Partners [Abstract]                  
Investment in unconsolidated entities                 50,000us-gaap_EquityMethodInvestments
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember
Interest expense       $ 26,000us-gaap_InterestExpense
/ us-gaap_ScheduleOfEquityMethodInvestmentEquityMethodInvesteeNameAxis
= usnu_BrowardOncologyPartnersLlcMember